Indeed, a recent clinical trial incorporating 347 mild-to-moderate AD patients showed that PE with albumin replacement can slow the decline or stabilize AD symptoms [25]; however, the mechanism behind this is not clearly understood. Here, ALB is linked to Alzheimer disease.